Hsiao-Huei Tsou

Learn More
BACKGROUND Previous clinical trials have not proved that adding epidermal growth factor receptor inhibitors to chemotherapy confers a survival benefit for patients with advanced biliary tract cancer (ABTC). Whether the KRAS mutation status of tumor cells confounded the results of past studies is unknown. PATIENTS AND METHODS ABTC patients stratified by(More)
Multi-testing correction methods are usually applied in more than one single nucleotide polymorphisms (SNPs) of association analyses to determine the significance of results in the face of testing multiple hypotheses. One of the statistical methods applied in these analyses is called false discovery rate (FDR) procedure. In this study, we compared the FDR(More)
  • 1